Open access
Aug 2026
Dendritic Mesoporous Silica-Modified Decellularized Bone Matrix Scaffold for Sustained Teriparatide Delivery in Bone Defect Repair: Characterization, Drug Release, and In Vitro Biological Performance
The DBM-DMSN@TPTD scaffold offers a native bone microenvironment, sustained drug release, and osteogenic activity in vitro, and may support BMSC proliferation and osteogenic differentiation.
Lin Zhang, Wenbo Yang, Shi-Pu Jia et al.
· Pharmaceutics · 0 citations